Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
46 | 3 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 102919 |
96 | 2 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//INFECTIOUS DISEASES | 26037 |
3176 | 1 | RITONAVIR//ATAZANAVIR//LOPINAVIR | 2078 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | RITONAVIR | authKW | 1349625 | 11% | 39% | 228 |
2 | ATAZANAVIR | authKW | 1205868 | 7% | 56% | 141 |
3 | LOPINAVIR | authKW | 799725 | 6% | 42% | 126 |
4 | SAQUINAVIR | authKW | 765901 | 6% | 43% | 117 |
5 | DARUNAVIR | authKW | 558029 | 4% | 40% | 93 |
6 | AMPRENAVIR | authKW | 494015 | 3% | 63% | 52 |
7 | INDINAVIR | authKW | 447821 | 5% | 31% | 96 |
8 | TIPRANAVIR | authKW | 444814 | 2% | 67% | 44 |
9 | PROTEASE INHIBITORS | authKW | 420498 | 15% | 9% | 314 |
10 | NELFINAVIR | authKW | 390079 | 4% | 32% | 81 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Infectious Diseases | 33524 | 38% | 0% | 786 |
2 | Pharmacology & Pharmacy | 17695 | 53% | 0% | 1110 |
3 | Virology | 8832 | 16% | 0% | 331 |
4 | Immunology | 3413 | 21% | 0% | 426 |
5 | Microbiology | 2801 | 16% | 0% | 340 |
6 | Medical Laboratory Technology | 1467 | 5% | 0% | 96 |
7 | Chemistry, Analytical | 1036 | 11% | 0% | 227 |
8 | Biochemical Research Methods | 917 | 8% | 0% | 163 |
9 | Toxicology | 886 | 7% | 0% | 143 |
10 | Chemistry, Medicinal | 32 | 2% | 0% | 41 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CLIN PHARM 533 | 92885 | 0% | 88% | 7 |
2 | PK LTD | 75826 | 0% | 100% | 5 |
3 | ST STEPHENS | 75707 | 2% | 13% | 38 |
4 | INVEST MEDICAMENT | 57154 | 0% | 54% | 7 |
5 | PROGRAM HIV PREVENT TREATMENT IRD UMI 174 | 45495 | 0% | 100% | 3 |
6 | SERGAS SERV GALEGA SAUDE | 45495 | 0% | 100% | 3 |
7 | ANTIVIRAL PHARMACOL | 42188 | 0% | 35% | 8 |
8 | INT AIDS THER Y EVALUAT | 40438 | 0% | 67% | 4 |
9 | STAT DATA ANAL | 36970 | 1% | 10% | 24 |
10 | HIV NETHERLANDS AUSTRALIA THAILAND ABORAT | 34612 | 1% | 18% | 13 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ANTIVIRAL THERAPY | 59370 | 4% | 5% | 87 |
2 | HIV CLINICAL TRIALS | 53331 | 2% | 8% | 43 |
3 | AIDS | 35213 | 7% | 2% | 143 |
4 | HIV MEDICINE | 30424 | 2% | 4% | 48 |
5 | THERAPEUTIC DRUG MONITORING | 29512 | 4% | 2% | 86 |
6 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 19482 | 4% | 2% | 76 |
7 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 16621 | 8% | 1% | 164 |
8 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 11230 | 5% | 1% | 98 |
9 | AIDS REVIEWS | 10514 | 1% | 5% | 14 |
10 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 7384 | 4% | 1% | 78 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RITONAVIR | 1349625 | 11% | 39% | 228 | Search RITONAVIR | Search RITONAVIR |
2 | ATAZANAVIR | 1205868 | 7% | 56% | 141 | Search ATAZANAVIR | Search ATAZANAVIR |
3 | LOPINAVIR | 799725 | 6% | 42% | 126 | Search LOPINAVIR | Search LOPINAVIR |
4 | SAQUINAVIR | 765901 | 6% | 43% | 117 | Search SAQUINAVIR | Search SAQUINAVIR |
5 | DARUNAVIR | 558029 | 4% | 40% | 93 | Search DARUNAVIR | Search DARUNAVIR |
6 | AMPRENAVIR | 494015 | 3% | 63% | 52 | Search AMPRENAVIR | Search AMPRENAVIR |
7 | INDINAVIR | 447821 | 5% | 31% | 96 | Search INDINAVIR | Search INDINAVIR |
8 | TIPRANAVIR | 444814 | 2% | 67% | 44 | Search TIPRANAVIR | Search TIPRANAVIR |
9 | PROTEASE INHIBITORS | 420498 | 15% | 9% | 314 | Search PROTEASE+INHIBITORS | Search PROTEASE+INHIBITORS |
10 | NELFINAVIR | 390079 | 4% | 32% | 81 | Search NELFINAVIR | Search NELFINAVIR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |